Learning Objectives:
1. Describe genetic variation and biology of LRRK2, as well as trial design for LRRK2 related therapies
2. Describe genetic variation and biology of GBA1, as well as trial design for GBA1 related therapies
3. Discuss how to incorporate common genetic variation (single nucleotide variants / polymorphisms - SNVs) into clinical trials for targeted therapies